Literature DB >> 14519939

Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids.

Yuki Hasebe1, Kiyoshi Egawa, Yoko Yamazaki, Setsuko Kunimoto, Yasuaki Hirai, Yoshiteru Ida, Kiyoshi Nose.   

Abstract

Screening using a reporter under the control of the hypoxia-response element (HRE) identified several flavonoids and homoisoflavonoids that inhibit the activation of HRE under hypoxic conditions. Among various compounds, isorhamnetin, luteolin, quercetin, and methyl ophiopogonanone B (MOB) were effective at 3 to 9 microg/ml in inhibiting the reporter activity. The expression of vascular endothelial growth factor (VEGF) mRNA during hypoxia was also inhibited by MOB in HepG2 cells, but the effective doses were 10 to 20 microg/ml. MOB caused destabilization of hypoxia-inducible factor (HIF)-1alpha, as revealed by Western blotting, that was dependent on proteasome activity and the tumor suppressor, p53. The tubular formation and migration of human umbilical vein endothelial cells was also inhibited by MOB. MOB is expected to act as an inhibitor of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519939     DOI: 10.1248/bpb.26.1379

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

Authors:  Aurélie de Rus Jacquet; Mitali Arun Tambe; Sin Ying Ma; George P McCabe; Jay Hansford C Vest; Jean-Christophe Rochet
Journal:  J Ethnopharmacol       Date:  2017-01-11       Impact factor: 4.360

2.  Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.

Authors:  Halesha D Basavarajappa; Bit Lee; Seung-Yong Seo; Timothy W Corson; Hyungjun Lee; Rania S Sulaiman; Hongchan An; Carlos Magaña; Mehdi Shadmand; Alexandra Vayl; Gangaraju Rajashekhar; Eun-Yeong Kim; Young-Ger Suh; Kiho Lee
Journal:  J Med Chem       Date:  2015-06-16       Impact factor: 7.446

Review 3.  Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.

Authors:  Francisco Javier Rodríguez-Jiménez; Victoria Moreno-Manzano
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

Review 5.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 6.  Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Curr Drug Targets       Date:  2006-03       Impact factor: 3.465

7.  In vitro action of flavonoids in the canine malignant histiocytic cell line DH82.

Authors:  Gabriel Silva; Ana Lúcia Fachin; Renê O Beleboni; Suzelei C França; Mozart Marins
Journal:  Molecules       Date:  2013-12-12       Impact factor: 4.411

8.  A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease.

Authors:  Xia Wang; Xue Xu; Weiyang Tao; Yan Li; Yonghua Wang; Ling Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-29       Impact factor: 2.629

9.  The phytoestrogen quercetin impairs steroidogenesis and angiogenesis in swine granulosa cells in vitro.

Authors:  Sujen Eleonora Santini; Giuseppina Basini; Simona Bussolati; Francesca Grasselli
Journal:  J Biomed Biotechnol       Date:  2009-06-01

10.  Khellin and visnagin differentially modulate AHR signaling and downstream CYP1A activity in human liver cells.

Authors:  Radim Vrzal; Katrin Frauenstein; Peter Proksch; Josef Abel; Zdenek Dvorak; Thomas Haarmann-Stemmann
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.